Steroid-assisted drug delivery with chemical peels for lichen amyloidosis: A case series

Cutaneous amyloidosis is a chronic dermatologic problem that can be extremely frustrating to patients and for which there are limited therapeutic options, often of inadequate efficacy. Patient quality of life is affected by the severe pruritus and cosmetic disfigurement of their lesions. First-line therapy for this condition is potent topical corticosteroids, but therapeutic efficacy is often limited by ineffective drug delivery to the target site. Intralesional kenalog can be a useful alternative for those with small, localized areas of disease involvement.